Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling

被引:57
作者
Jenkins, Jean
Calzone, Kathleen A. [1 ]
Dimond, Eileen
Liewehr, David J.
Steinberg, Seth M.
Jourkiv, Oxana
Klein, Pam
Soballe, Peter W.
Prindiville, Sheila A.
Kirsch, Ilan R.
机构
[1] Natl Human Genome Res, NIH, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Genet Branch, Bethesda, MD 20892 USA
[3] NCI, Ctr Canc Res, Biostat & Data Management Sect, Bethesda, MD 20892 USA
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA
[6] Amgen Inc, Seattle, WA USA
关键词
genetic testing; genetic counseling; BRCA1/BRCA2; result disclosure; risk communication;
D O I
10.1097/GIM.0b013e31812e6220
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: This study evaluated whether phone results were equivalent to in-person result disclosure for individuals undergoing BRCA1/2 predisposition genetic testing. Methods: A total of 111 of 136 subjects undergoing education and counseling for BRCA1/2 predisposition genetic testing agreed to randomization to phone or in-person result disclosure. Content and format for both sessions were standardized. Data from the State-Trait Anxiety Inventory and the Psychological General Well-Being index were collected at baseline and then again at 1 week and 3 months after disclosure of test results. Baseline measures were administered after the following had occurred: counseling/education session had been conducted, informed consent had been obtained, and decision to be tested had been made. Satisfaction and cost assessments were administered after the result session. At 1 week, participants were asked their preferred method of result disclosure. Results: There were no differences in anxiety and general well-being measures between 50 phone and 52 in-person results disclosure. Both groups reported similar rates of satisfaction with services. Among those with a preference, 77% preferred the notification method assigned. There was a statistically significant preference for phone results among the 23% who did not prefer the method assigned. Greater costs were associated with in-person result disclosure. Conclusions: These data suggest that phone results are a reasonable alternative to traditional in-person BRCA1/2 genetic test disclosure without any negative psychologic outcomes or compromise in knowledge. However, further study is needed in a more clinically representative population to confirm these findings.
引用
收藏
页码:487 / 495
页数:9
相关论文
共 34 条
[21]   Reimbursement for telephone care [J].
Melzer, SM ;
Poole, SR .
PEDIATRICS, 2002, 109 (02) :290-293
[22]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71
[23]  
Ormond K E, 2000, J Genet Couns, V9, P63, DOI 10.1023/A:1009433224504
[24]  
Sangha Karan K, 2003, J Genet Couns, V12, P171, DOI 10.1023/A:1022663324006
[25]   Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients [J].
Schwartz, MD ;
Lerman, C ;
Brogan, B ;
Peshkin, BN ;
Halbert, CH ;
DeMarco, T ;
Lawrence, W ;
Main, D ;
Finch, C ;
Magnant, C ;
Pennanen, M ;
Tsangaris, T ;
Willey, S ;
Isaacs, C .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :1823-1829
[26]  
Spielberger CD, 1977, STATE TRAIT ANXIETY
[27]  
Stone P W, 1998, Image J Nurs Sch, V30, P229, DOI 10.1111/j.1547-5069.1998.tb01297.x
[28]   The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds [J].
Tavtigian, SV ;
Simard, J ;
Rommens, J ;
Couch, F ;
ShattuckEidens, D ;
Neuhausen, S ;
Merajver, S ;
Thorlacius, S ;
Offit, K ;
StoppaLyonnet, D ;
Belanger, C ;
Bell, R ;
Berry, S ;
Bogden, R ;
Chen, Q ;
Davis, T ;
Dumont, M ;
Frye, C ;
Hattier, T ;
Jammulapati, S ;
Janecki, T ;
Jiang, P ;
Kehrer, R ;
Leblanc, JF ;
Mitchell, JT ;
McArthurMorrison, J ;
Nguyen, K ;
Peng, Y ;
Samson, C ;
Schroeder, M ;
Snyder, SC ;
Steele, L ;
Stringfellow, M ;
Stroup, C ;
Swedlund, B ;
Swensen, J ;
Teng, D ;
Thomas, A ;
Tran, T ;
Tran, T ;
Tranchant, M ;
WeaverFeldhaus, J ;
Wong, AKC ;
Shizuya, H ;
Eyfjord, JE ;
CannonAlbright, L ;
Labrie, F ;
Skolnick, MH ;
Weber, B ;
Kamb, A .
NATURE GENETICS, 1996, 12 (03) :333-337
[29]   GENETIC SERVICES FOR FAMILIAL CANCER-PATIENTS - A SURVEY OF NATIONAL-CANCER-INSTITUTE CANCER CENTERS [J].
THOMPSON, JA ;
WIESNER, GL ;
SELLERS, TA ;
VACHON, C ;
AHRENS, M ;
POTTER, JD ;
SUMPMANN, M ;
KERSEY, J .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (19) :1446-1455
[30]   A Counselling Model for BRCA1/2 Genetic Susceptibility Testing [J].
Iris van Oostrom ;
Aad Tibben .
Hereditary Cancer in Clinical Practice, 2 (1)